The fractional catabolic rate of apoA-I is significantly increased, whereas the absolute production of apoA-I is inhibited in T2DM patients and thus causes a decrease in plasma apoA-I levels [21–23]. The gene discussed is APOA1; the disease is type 2 diabetes mellitus.